301 related articles for article (PubMed ID: 27637362)
1. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
[TBL] [Abstract][Full Text] [Related]
2. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
3. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs About Medication Questionnaire.
Beck EM; Vögelin R; Wirtz M; Cavelti M; Kvrgic S; Vauth R
J Nerv Ment Dis; 2012 Jan; 200(1):33-43. PubMed ID: 22210360
[TBL] [Abstract][Full Text] [Related]
4. Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.
Vassileva IV; Milanova VK
Folia Med (Plovdiv); 2012; 54(4):62-8. PubMed ID: 23441471
[TBL] [Abstract][Full Text] [Related]
5. Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study.
Shiyanbola OO; Unni E; Huang YM; Lanier C
BMJ Open; 2018 Nov; 8(11):e022803. PubMed ID: 30478112
[TBL] [Abstract][Full Text] [Related]
6. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
7. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
[TBL] [Abstract][Full Text] [Related]
8. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.
Horne R; Parham R; Driscoll R; Robinson A
Inflamm Bowel Dis; 2009 Jun; 15(6):837-44. PubMed ID: 19107771
[TBL] [Abstract][Full Text] [Related]
9. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
10. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
[TBL] [Abstract][Full Text] [Related]
11. Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis.
Uhlmann C; Kaehler J; Harris MS; Unser J; Arolt V; Lencer R
J Psychiatr Pract; 2014 Sep; 20(5):405-10. PubMed ID: 25226204
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
13. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
14. A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia.
Dibonaventura M; Gabriel S; Dupclay L; Gupta S; Kim E
BMC Psychiatry; 2012 Mar; 12():20. PubMed ID: 22433036
[TBL] [Abstract][Full Text] [Related]
15. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
16. The impact of self-stigmatization on medication attitude in schizophrenia patients.
Feldhaus T; Falke S; von Gruchalla L; Maisch B; Uhlmann C; Bock E; Lencer R
Psychiatry Res; 2018 Mar; 261():391-399. PubMed ID: 29353769
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
18. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.
Mohamed S; Rosenheck R; McEvoy J; Swartz M; Stroup S; Lieberman JA
Schizophr Bull; 2009 Mar; 35(2):336-46. PubMed ID: 18586692
[TBL] [Abstract][Full Text] [Related]
20. Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
Vassileva I; Milanova V; Asan T
Community Ment Health J; 2014 Oct; 50(7):854-61. PubMed ID: 24452824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
